We are live on ! Find out more
TMED

T. Rowe Price Health Care ETF

3 hedge funds and large institutions have $2.3M invested in T. Rowe Price Health Care ETF in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

865% more capital invested

Capital invested by funds: $238K → $2.3M (+$2.06M)

200% more funds holding

Funds holding: 13 (+2)

14.82% more ownership

Funds ownership: 2.4%17.21% (+15%)

Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
FTUS
1
Flow Traders U.S.
New York
$1.26M +$1.19M +47,196 New
Citadel Advisors
2
Citadel Advisors
Florida
$794K +$508K +20,189 +211%
EFS
3
Essex Financial Services
Connecticut
$243K +$229K +9,100 New

TMED Hedge Fund Activity: Q3 2025 in Review

3 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in T. Rowe Price Health Care ETF (TMED) for Q3 2025, worth a combined $2.3M — up 865% from $238K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TMED positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Flow Traders U.S., opening a new position worth an estimated $1.19M.

  • 3 institutional investors held T. Rowe Price Health Care ETF (TMED) as of Q3 2025, up from 1 in Q2 2025.
  • Funds reported $2.3M of T. Rowe Price Health Care ETF stock for Q3 2025, up 865% quarter-over-quarter.
  • 2 funds opened new T. Rowe Price Health Care ETF positions in Q3 2025 and 0 closed out, a net change of +2 holders.
  • The largest T. Rowe Price Health Care ETF buyer in Q3 2025 was Flow Traders U.S., an estimated $1.19M added.

Based on aggregated 13F filings for Q3 2025.